# Extended Delivery of Bupivacaine Study in Herniorrhaphy

> **NCT04102267** · PHASE4 · COMPLETED · sponsor: **Heron Therapeutics** · enrollment: 32 (actual)

## Conditions studied

- Analgesia

## Interventions

- **DRUG:** Bupivacaine liposome injectable suspension
- **DRUG:** Bupivacaine HCl without epinephrine via continuous infusion

## Key facts

- **NCT ID:** NCT04102267
- **Lead sponsor:** Heron Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-02
- **Primary completion:** 2018-09-03
- **Final completion:** 2018-10-26
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2019-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04102267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04102267, "Extended Delivery of Bupivacaine Study in Herniorrhaphy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04102267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*